Expired Tender Belgium ICB TOT Ref. 31228976

Contract notice: Antineoplastic Tender in Belgium - 31228976

Tender notice from Belgium, published on 04 Mar 2019.

Executive Summary

The CHIREC has issued a Tender notice for the procurement of a Contract notice: Antineoplastic and immunomodulating agents in the Belgium. This Tender notice was published on 04 Mar 2019 and is scheduled to close on 11 Apr 2019, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 31228976, while the tender notice number is 099838-2019 and Register on the platform.

Key facts

Summary
Contract notice: Antineoplastic and immunomodulating agents
TOT Ref. No.
31228976
Document Ref. No.
099838-2019
Country
Belgium
Notice type
Tender
Competition
ICB
Publication date
04 Mar 2019
Bid deadline
11 Apr 2019
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
Antineoplastic and immunomodulating agents
Description: Contract notice: Antineoplastic and immunomodulating agents
Authority Type: Other
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: The most economic tender
CPV code: 33652000, 33000000, 33652000, 33000000
CPV Description: Antineoplastic and Immunomodulating Agents.
Medical Equipment, Pharmaceuticals and Personal Care Products.
Framework Agreement for the Purchase of Infliximab and Associated Services
Reference Number: Chirec-2018-018
See II.2.4).
Main Site: Chirec, Boulevard du Triomphe 201 to 1160 Brussels (Auderghem)
Purpose of the market
The present market consists of the conclusion of a framework agreement for the supply of infliximab 100 mg (ATC Code L04AB02) and its associated services.
The aim of the framework agreement is to identify the 2 tenderers who submitted the most economically advantageous tenders on the basis of the award criteria and to apply to them the distribution key following: the supply of the 90% of the market in terms of quantity will be entrusted to the tenderer class in first position, the 10%Remainder to the bidder ranks in second position.
Place of delivery
Chirec ASBL, sites:
- Hospital Delta Boulevard du Triomphe 201 1160 Brussels,
- Hospital Braine-l'Alleud-Waterloo Rue Wayez 35 1420 Braine-l'Alleud,
- Clinic Ste-Anne-St-Remi Boulevard J. Graindor 66 1070 Brussels.
Allotment
Given its indivisible character, the present march is not divided into loOptions
Nant.
Variants
Neant.
Duration of the market
The contract is concluded for a period of 2 years with clauses of renewal.
Except in case of notification to the contrary, the market is tacitly renewed for a renewable period of 2 times 1 year. The maximum number of renewals is 2, bringing the maximum duration of the public market to 4 years. The contracting authority may notify the contracting authoritye by letter recommended at least 3 months before the date of expiry of the public contract, the non-renewal of this market. If the contract is not renewed, the successful tenderer may not demand any compensation in this respect. Orders placed before the date of expiry of the market remain executable. The DUME, by which the tenderer declares that he will not not find in one of the situations of exclusionreferred to in Articles 67 to 69 of the Law of 17.6.2016.
The DUME, whereby the tenderer declares that he satisfies the following selection criteria:
1) A statement concerning the total turnover covered by the last 3 financial years available according to the date of creation or the beginning of the activity of the tenderer;
2) A certificate of insurance of coverOccupational risks and operating risks linked to the field of activity covered by the contract and any other insurance required by this contract.
Tenders can only be submitted electronically on the e-Tendering website https: / /eten.publicprocurement.be/.
Internet address (URL): www.chirec.be

Documents

Tender Notice
Login to view

Similar tenders

Belgium Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: Antineoplastic and immunomodulating agents was 11 Apr 2019. Bidding is closed.

This tender has been issued by CHIREC in Belgium.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33652000 - Antineoplastic and immunomodulating agents, 33000000 - Medical equipments, pharmaceuticals and personal care products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 31228976. The purchaser document reference is 099838-2019.

See the Similar Tenders section on this page or browse other tenders from Belgium.

This tender falls under Materials and Products in Belgium. Suppliers in these sectors can track similar Belgium tenders using CPV-based alerts.